Mealey's (September 26, 2022, 1:12 PM EDT) -- WASHINGTON, D.C. — Filing an amicus curiae brief in response to a request from the U.S. Supreme Court in a dispute over the nature of enablement in patent claims, the U.S. solicitor general (SG), on behalf of the United States, calls petitioner Amgen Inc.’s arguments without merit and case-specific, making a grant of certiorari inappropriate....